grepcent public filings, reorganized for comparison

NATIONAL HEALTHCARE CORP (NHC)

CIK: 0001047335. SIC: 8051 Services-Skilled Nursing Care Facilities. Latest 10-K as of: 2026-02-26.

SIC breadcrumb: Services > SIC Major Group 80 > SIC 8051 Services-Skilled Nursing Care Facilities

SEC company page: https://www.sec.gov/edgar/browse/?CIK=1047335. Latest filing source: 0001437749-26-005910.

Informational only. Descriptive public-record data — not a rating, forecast, or investment advice. See Disclaimer.

At a glance

FY2025 · period end 2025-12-31 · filed 2026-02-26 · accession 0001437749-26-005910 · source: SEC companyfacts

Revenue
1,517,781,000 USD verified
Net income
120,015,000 USD verified
Assets
1,526,419,000 USD verified
Free cash flow
148,632,000 USD computed
Net margin
7.91% computed
Operating margin
8.46% computed
Revenue YoY
+16.09% computed
ROE
11.23% computed

Computed values are grepcent-computed from the verified facts above and may differ from ratios the company itself reports. Free cash flow = operating cash flow − capital expenditures. Net margin = net income ÷ revenue. Operating margin = operating income ÷ revenue. Revenue YoY = FY2025 revenue ÷ FY2024 revenue − 1 (consecutive fiscal years only). ROE = net income ÷ period-end stockholders' equity.

No market price, no rating, no forecast on this site. Not investment advice.

Peer & cluster context

Peer percentile fingerprint

NHC ratios vs SIC peers. Source: grepcent computed from latest SEC companyfacts ratios; peer set SIC major-group 80; per-ratio N printed.NHC ratios vs SIC peers. Source: grepcent computed from latest SEC companyfacts ratios; peer set SIC major-group 80; per-ratio N printed.RatioNHCPeer medianPercentileNNet margin7.9%3.2%8056Operating margin8.5%5.5%6451Revenue growth16.1%11.8%6257FCF margin9.8%5.4%8148ROE11.2%7.9%6553ROA7.9%2.8%8258Liabilities / equity0.421.132354Current ratio1.821.636058

Percentile = share of the N covered peers reporting that ratio whose value is lower (ties counted half); computed among grepcent-covered companies in SIC major-group 80 SIC Major Group 80, not the whole market. A higher percentile means a higher value of the ratio, not a better company. Ratios with fewer than 8 reporting peers are omitted. Latest reported values per company; fiscal periods may differ. Descriptive arithmetic - not a score, rating, or ranking.

Selected Fundamentals

MetricValueUnitFYFiled
Revenue1,517,781,000USD20252026-02-26
Net income120,015,000USD20252026-02-26
Assets1,526,419,000USD20252026-02-26

Financials

Annual standardized facts from SEC companyfacts as of latest extracted filing date 2026-02-26. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001047335.json. Derived margins, ratios, and free cash flow are computed from the extracted annual SEC facts.

Download these verified figures (annual + quarterly, with per-value filing provenance): JSON · CSV

Flow metrics use full-year FY periods from 10-K/10-K/A filings; balance-sheet metrics use FY-end instants. Free cash flow = operating cash flow - capital expenditures. Missing metrics are omitted rather than fabricated.

Metric2016201720182019202020212022202320242025
Revenue923,580,000963,895,000980,349,000996,383,0001,028,217,0001,074,302,0001,085,738,0001,141,544,0001,307,382,0001,517,781,000
Net income50,538,00056,205,00058,964,00068,211,00041,871,000138,590,00022,445,00066,798,000101,927,000120,015,000
Operating income60,542,00054,110,00056,076,00049,038,00048,155,00050,925,00031,896,00057,458,00089,895,000128,352,000
Diluted EPS3.323.693.874.442.728.991.454.346.537.67
Operating cash flow90,882,00094,466,00098,435,000100,103,000203,259,00062,394,0008,742,000111,216,000107,303,000185,078,000
Capital expenditures62,601,00032,347,00029,772,00026,400,00021,873,00039,399,00030,200,00027,901,00027,600,00036,446,000
Dividends paid25,795,00028,237,00029,827,00031,208,00031,921,00032,030,00034,604,00035,560,00036,964,00038,704,000
Share buybacks8,195,0000.00867,000872,00053,000836,0009,903,0002,482,00013,502,00014,730,000
Assets1,087,447,0001,096,526,0001,080,948,0001,286,648,0001,362,132,0001,403,396,0001,275,450,0001,310,796,0001,524,429,0001,526,419,000
Liabilities417,836,000393,094,000346,491,000507,579,000563,872,000494,936,000397,936,000400,316,000541,266,000451,904,000
Stockholders' equity669,611,000702,738,000733,278,000778,593,000795,177,000903,004,000874,276,000908,752,000980,161,0001,068,772,000
Cash and cash equivalents26,335,00059,118,00043,247,00050,334,000147,093,000107,607,00058,667,000107,076,00076,121,00092,829,000
Free cash flow28,281,00062,119,00068,663,00073,703,000181,386,00022,995,000-21,458,00083,315,00079,703,000148,632,000

Ratios

ROE and ROA use period-end equity/assets. Liabilities / equity uses total liabilities divided by stockholders' equity. Current ratio uses current assets divided by current liabilities when both are reported.

Metric2016201720182019202020212022202320242025
Net margin5.47%5.83%6.01%6.85%4.07%12.90%2.07%5.85%7.80%7.91%
Operating margin6.56%5.61%5.72%4.92%4.68%4.74%2.94%5.03%6.88%8.46%
Return on equity7.55%8.00%8.04%8.76%5.27%15.35%2.57%7.35%10.40%11.23%
Return on assets4.65%5.13%5.45%5.30%3.07%9.88%1.76%5.10%6.69%7.86%
Liabilities / equity0.620.560.470.650.710.550.460.440.550.42
Current ratio1.932.122.041.751.621.621.791.891.811.82

Industry Peer Context

Each number-line places NHC against the min, median, and max of latest reported values among companies in the same SIC industry when at least three peers report that ratio.

Net margin peer context

NHC Net margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 8051; peer count 3.NHC Net margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 8051; peer count 3.3 SIC peersMin 3.6%Median 6.8%Max 7.9%NHC 7.9%

Operating margin peer context

NHC Operating margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 8051; peer count 3.NHC Operating margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 8051; peer count 3.3 SIC peersMin 5.9%Median 8.4%Max 8.5%NHC 8.5%

ROE peer context

NHC ROE versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 8051; peer count 3.NHC ROE versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 8051; peer count 3.3 SIC peersMin 11.2%Median 15.4%Max 20.2%NHC 11.2%

ROA peer context

NHC ROA versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 8051; peer count 3.NHC ROA versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 8051; peer count 3.3 SIC peersMin 3.4%Median 6.3%Max 7.9%NHC 7.9%

Financial Bridges

Waterfall figures reconcile reported SEC companyfacts components. Missing bridges are omitted when required components are not present for the same fiscal year.

Free cash flow = operating cash flow - capital expenditures

NHC FY2025 free cash flow bridge from reported figures.NHC FY2025 free cash flow bridge from reported figures.NHC free cash flow bridgeFY2025: operating cash flow less capital expendituresSource: SEC companyfacts FY2025.Free cash flow bridgeReported amount$0.0B$125.0M$250.0M$185.1MOperating cash flow-$36.4MCapex$148.6MFree cash flow

Figure provenance: SEC companyfacts FY 2025. Operating cash flow: accession 0001437749-26-005910; concept NetCashProvidedByUsedInOperatingActivities; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities | Capital expenditures: accession 0001437749-26-005910; concept PaymentsToAcquirePropertyPlantAndEquipment; source concepts us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | Free cash flow: accession 0001437749-26-005910; concept NetCashProvidedByUsedInOperatingActivities - PaymentsToAcquirePropertyPlantAndEquipment; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

Financial Charts

NHC revenue, last 5 periods. Source: SEC companyfacts FY2025.NHC revenue, last 5 periods. Source: SEC companyfacts FY2025.NHC RevenueLatest point: FY2025 = $1.5BSource: SEC companyfacts FY2025.Fiscal yearReported revenue$0.0B$1.0B$2.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005910; filed 2026-02-26. Concept: Revenues. Source concepts: us-gaap:Revenues.

NHC net income, last 5 periods. Source: SEC companyfacts FY2025.NHC net income, last 5 periods. Source: SEC companyfacts FY2025.NHC Net incomeLatest point: FY2025 = $120.0MSource: SEC companyfacts FY2025.Fiscal yearNet income$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005910; filed 2026-02-26. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.

NHC operating income, last 5 periods. Source: SEC companyfacts FY2025.NHC operating income, last 5 periods. Source: SEC companyfacts FY2025.NHC Operating incomeLatest point: FY2025 = $128.4MSource: SEC companyfacts FY2025.Fiscal yearOperating income$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005910; filed 2026-02-26. Concept: OperatingIncomeLoss. Source concepts: us-gaap:OperatingIncomeLoss.

NHC diluted eps, last 5 periods. Source: SEC companyfacts FY2025.NHC diluted eps, last 5 periods. Source: SEC companyfacts FY2025.NHC Diluted EPSLatest point: FY2025 = $7.67/shareSource: SEC companyfacts FY2025.Fiscal yearDiluted EPS (USD/share)$0.00/share$7.50/share$15.00/shareFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005910; filed 2026-02-26. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.

NHC operating cash flow, last 5 periods. Source: SEC companyfacts FY2025.NHC operating cash flow, last 5 periods. Source: SEC companyfacts FY2025.NHC Operating cash flowLatest point: FY2025 = $185.1MSource: SEC companyfacts FY2025.Fiscal yearOperating cash flow$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005910; filed 2026-02-26. Concept: NetCashProvidedByUsedInOperatingActivities. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities.

NHC capital expenditures, last 5 periods. Source: SEC companyfacts FY2025.NHC capital expenditures, last 5 periods. Source: SEC companyfacts FY2025.NHC Capital expendituresLatest point: FY2025 = $36.4MSource: SEC companyfacts FY2025.Fiscal yearCapital expenditures$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005910; filed 2026-02-26. Concept: PaymentsToAcquirePropertyPlantAndEquipment. Source concepts: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

NHC dividends paid, last 5 periods. Source: SEC companyfacts FY2025.NHC dividends paid, last 5 periods. Source: SEC companyfacts FY2025.NHC Dividends paidLatest point: FY2025 = $38.7MSource: SEC companyfacts FY2025.Fiscal yearDividends paid$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005910; filed 2026-02-26. Concept: PaymentsOfDividendsCommonStock. Source concepts: us-gaap:PaymentsOfDividendsCommonStock.

NHC share buybacks, last 5 periods. Source: SEC companyfacts FY2025.NHC share buybacks, last 5 periods. Source: SEC companyfacts FY2025.NHC Share buybacksLatest point: FY2025 = $14.7MSource: SEC companyfacts FY2025.Fiscal yearShare buybacks$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005910; filed 2026-02-26. Concept: PaymentsForRepurchaseOfCommonStock. Source concepts: us-gaap:PaymentsForRepurchaseOfCommonStock.

NHC assets, last 5 periods. Source: SEC companyfacts FY2025.NHC assets, last 5 periods. Source: SEC companyfacts FY2025.NHC AssetsLatest point: FY2025 = $1.5BSource: SEC companyfacts FY2025.Fiscal yearAssets$0.0B$1.0B$2.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005910; filed 2026-02-26. Concept: Assets. Source concepts: us-gaap:Assets.

NHC liabilities, last 5 periods. Source: SEC companyfacts FY2025.NHC liabilities, last 5 periods. Source: SEC companyfacts FY2025.NHC LiabilitiesLatest point: FY2025 = $451.9MSource: SEC companyfacts FY2025.Fiscal yearLiabilities$0.0B$375.0M$750.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005910; filed 2026-02-26. Concept: Liabilities. Source concepts: us-gaap:Liabilities.

NHC stockholders' equity, last 5 periods. Source: SEC companyfacts FY2025.NHC stockholders' equity, last 5 periods. Source: SEC companyfacts FY2025.NHC Stockholders' equityLatest point: FY2025 = $1.1BSource: SEC companyfacts FY2025.Fiscal yearStockholders' equity$0.0B$1.0B$2.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005910; filed 2026-02-26. Concept: StockholdersEquity. Source concepts: us-gaap:StockholdersEquity.

NHC cash and cash equivalents, last 5 periods. Source: SEC companyfacts FY2025.NHC cash and cash equivalents, last 5 periods. Source: SEC companyfacts FY2025.NHC Cash and cash equivalentsLatest point: FY2025 = $92.8MSource: SEC companyfacts FY2025.Fiscal yearCash and cash equivalents$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005910; filed 2026-02-26. Concept: CashAndCashEquivalentsAtCarryingValue. Source concepts: us-gaap:CashAndCashEquivalentsAtCarryingValue.

NHC free cash flow, last 5 periods. Source: SEC companyfacts FY2025.NHC free cash flow, last 5 periods. Source: SEC companyfacts FY2025.NHC Free cash flowLatest point: FY2025 = $148.6MSource: SEC companyfacts FY2025.Fiscal yearFree cash flow-$250.0M$0.0B$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005910; filed 2026-02-26. Concept: NetCashProvidedByUsedInOperatingActivities - PaymentsToAcquirePropertyPlantAndEquipment. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

As-reported value updates

1 tracked difference above grepcent's stated thresholds were found between the earliest XBRL-filed value and the value currently on file for the same fiscal period.

View the filing-by-filing ledger →

Quarterly

Quarterly standardized facts from SEC companyfacts as of latest extracted filing date 2026-08-06. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001047335.json.

Flow metrics use discrete quarter-length periods from 10-Q/10-Q/A filings. Q4 revenue and net income are derived only when annual FY and nine-month YTD facts exist for the same fiscal year; derived Q4 values are labeled. EPS Q4 is not derived.

QuarterEnd DateRevenueNet IncomeDiluted EPSMethod
2022-Q32022-09-30-0.16reported discrete quarter
2023-Q12023-03-310.76reported discrete quarter
2023-Q22023-06-301.06reported discrete quarter
2023-Q32023-09-30288,485,00010,388,0000.68reported discrete quarter
2023-Q42023-12-31300,914,00028,406,000derived Q4 = FY annual - nine-month YTD
2024-Q12024-03-31297,176,00026,213,0001.69reported discrete quarter
2024-Q22024-06-30300,658,00026,844,0001.73reported discrete quarter
2024-Q32024-09-30340,198,00042,789,0002.73reported discrete quarter
2024-Q42024-12-31369,350,0006,081,000derived Q4 = FY annual - nine-month YTD
2025-Q12025-03-31373,697,00032,205,0002.07reported discrete quarter
2025-Q22025-06-30374,910,00023,722,0001.52reported discrete quarter
2025-Q32025-09-30382,661,00039,239,0002.50reported discrete quarter
2025-Q42025-12-31386,513,00024,849,000derived Q4 = FY annual - nine-month YTD
2026-Q12026-03-31381,821,00035,857,0002.27reported discrete quarter
2026-Q22026-06-30408,025,00040,319,0002.54reported discrete quarter

Quarterly Charts

NHC quarterly revenue, last 12 periods. Source: SEC companyfacts 2026-Q2.NHC quarterly revenue, last 12 periods. Source: SEC companyfacts 2026-Q2.NHC Quarterly RevenueLatest point: 2026-Q2 = $408.0MSource: SEC companyfacts 2026-Q2.Fiscal quarterQuarterly Revenue$0.0B$250.0M$500.0M2023-Q32023-Q42024-Q12024-Q22024-Q32024-Q42025-Q12025-Q22025-Q32025-Q42026-Q12026-Q2

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001437749-26-026199; filed 2026-08-06. Concept: Revenues. Source concepts: us-gaap:Revenues.

NHC quarterly net income, last 12 periods. Source: SEC companyfacts 2026-Q2.NHC quarterly net income, last 12 periods. Source: SEC companyfacts 2026-Q2.NHC Quarterly Net incomeLatest point: 2026-Q2 = $40.3MSource: SEC companyfacts 2026-Q2.Fiscal quarterQuarterly Net income$0.0B$125.0M$250.0M2023-Q32023-Q42024-Q12024-Q22024-Q32024-Q42025-Q12025-Q22025-Q32025-Q42026-Q12026-Q2

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001437749-26-026199; filed 2026-08-06. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.

NHC quarterly diluted eps, last 12 periods. Source: SEC companyfacts 2026-Q2.NHC quarterly diluted eps, last 12 periods. Source: SEC companyfacts 2026-Q2.NHC Quarterly Diluted EPSLatest point: 2026-Q2 = $2.54/shareSource: SEC companyfacts 2026-Q2.Fiscal quarterQuarterly Diluted EPS (USD/share)-$0.50/share$0.00/share$4.00/share2022-Q32023-Q12023-Q22023-Q32024-Q12024-Q22024-Q32025-Q12025-Q22025-Q32026-Q12026-Q2

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001437749-26-026199; filed 2026-08-06. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.

Business

Read NHC's verbatim Item 1 Business section from its latest 10-K: Business.

Risk Factors

Read NHC's verbatim Item 1A Risk Factors from its latest 10-K: Risk Factors.

Latest quarter (10-Q)

Latest 10-Q source: 0001437749-26-026199.

Extracted structurally from real Item 2 body heading to real Item 3/4 boundary. Confidence: high. Filing date: 2026-08-06. Report date: 2026-06-30.

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.

Forward–Looking Statements

References throughout this document to the Company include National HealthCare Corporation and its wholly owned subsidiaries. In accordance with the Securities and Exchange Commissions “Plain English” guidelines, this Quarterly Report on Form 10–Q has been written in the first person. In this document, the words “we”, “our”, “ours” and “us” refer only to National HealthCare Corporation and its wholly–owned subsidiaries and not any other person.

This Quarterly Report on Form 10–Q and other information we provide from time to time, contains certain “forward–looking” statements as that term is defined by the Private Securities Litigation Reform Act of 1995. All statements regarding our expected future financial position, results of operations or cash flows, continued performance improvements, ability to service and refinance our debt obligations, ability to finance growth opportunities, ability to control our patient care liability costs, ability to respond to changes in government regulations, ability to execute our three–year strategic plan, and similar statements including, without limitations, those containing words such as “believes”, “anticipates”, “expects”, “intends”, “estimates”, “plans”, and other similar expressions are forward–looking statements.

Forward–looking statements involve known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from those projected or contemplated in the forward–looking statements as a result of, but not limited to, the following factors:

Column 1Column 2
national and local economic conditions, including their effect on the availability and cost of labor, utilities and materials;
Column 1Column 2
the effect of government regulations and changes in regulations governing the healthcare industry, including our compliance with such regulations;
Column 1Column 2
changes in Medicare and Medicaid payment levels and methodologies and the application of such methodologies by the government and its fiscal intermediaries;
Column 1Column 2
liabilities and other claims asserted against us, including patient care liabilities, as well as the resolution of current litigation (see Note 17 to Interim Condensed Consolidated Financial Statements included in this Form 10-Q);
Column 1Column 2
the ability to attract and retain qualified personnel;
Column 1Column 2
the availability and terms of capital to fund acquisitions and capital improvements;

29

Table of Contents

Column 1Column 2
the competitive environment in which we operate;
Column 1Column 2
our need to make investments continually in our processes and information systems to protect the privacy of patients, partners and other persons and reduce the risk of successful cybersecurity attacks;
Column 1Column 2
damage to our reputation, regulatory penalties, legal claims and liability under state and federal laws that we could suffer upon any cybersecurity or privacy breaches;
Column 1Column 2
the ability to maintain and increase census levels; and
Column 1Column 2
demographic changes.

See the notes to the quarterly financial statements, and “Item 1. Business” in our 2025 Annual Report on Form 10–K for a discussion of various governmental regulations and other operating factors relating to the healthcare industry and the risk factors inherent in them. This may be found on our web site at www.nhccare.com. You should carefully consider these risks before making any investment in the Company. These risks and uncertainties are not the only ones facing us. There may be additional risks that we do not presently know of or that we currently deem immaterial. If any of the risks occur, our business, financial condition or results of operations could be materially adversely affected. In that case, the trading price of our shares of stock could decline, and you may lose all or part of your investment. Given these risks and uncertainties, we can give no assurances that these forward–looking statements will, in fact, transpire and, therefore, caution investors not to place undue reliance on them.

Overview

National HealthCare Corporation (“NHC” or the “Company”) is a leading provider of senior health care services. As of June 30, 2026, we operate or manage, through certain affiliates, 80 skilled nursing facilities with a total of 10,323 licensed beds, 26 assisted living facilities with 1,413 units, nine independent living facilities, three behavioral health hospitals, 34 homecare agencies, and 33 hospice agencies. We operate specialized care units within certain of our healthcare centers such as Alzheimer's disease care units and sub-acute nursing units. In addition, we provide insurance services, management and accounting services, and we lease properties to operators of skilled nursing and assisted living facilities. We operate in 9 states and are located primarily in the southeastern United States.

Summary of Goals and Areas of Focus

Occupancy

A primary area of management focus continues to be the rates of occupancy within our skilled nursing facilities. The overall census in owned and leased skilled nursing facilities for the three months ending June 30, 2026 was 90.1% compared to 89.4% for the same period a year ago.  For the six months ended June 30, 2026, overall census in our owned and leased skilled nursing facilities was 90.0% compared to 89.3% for the same period a year ago.

30

Table of Contents

Due to America’s healthcare labor shortage, the challenge of maintaining desirable patient census levels has been amplified. Management has undertaken a number of steps in order to best position our current and future health care facilities. This includes working internally to examine and improve systems to be most responsive to referral sources and payors, as well as find creative initiatives to retain and attract qualified healthcare professionals. Additionally, NHC is in various stages of partnerships with hospital systems, payors, and other post–acute alliances to better position ourselves so we are an active participant in the delivery of post-acute healthcare services.

Quality of Patient Care

CMS introduced the Five-Star Quality Rating System to help consumers, their families and caregivers compare skilled nursing facilities more easily. The Five-Star Quality Rating System gives each skilled nursing operation a rating ranging between one and five stars in various categories (five stars being the best). The Company has always strived for patient-centered care and quality outcomes as precursors to outstanding financial performance.

The tables below summarize NHC's overall performance in these Five-Star ratings versus the skilled nursing industry as of June 30, 2026:

NHC RatingsIndustry Ratings
Total number of skilled nursing facilities, end of period80
Number of 4 and 5-star rated skilled nursing facilities49
Percentage of 4 and 5-star rated skilled nursing facilities61%40%
Average rating for all skilled nursing facilities, end of period3.83.0

Development and Growth

We are undertaking to expand our senior care operations while protecting our existing operations and markets. The following table lists our recent development activities.

Type of OperationDescriptionSizeLocationPlaced in Service
Assisted Living FacilityNew Operation79 unitsTullahoma, TNQ2 2027

On June 1, 2026, the Company purchased the land, buildings, and other specified assets and assumed certain liabilities of five skilled nursing facilities from National Health Corporation (“National”) for a purchase price of $50,500,000. The operations have 639 licensed skilled nursing beds in the states of South Carolina and Tennessee.

On July 1, 2026, the Company purchased the land, facilities, and improvements of thirty-two skilled nursing facilities and three independent living facilities, currently leased by us as tenant, from National Health Investors (“NHI”) for a purchase price of $560,000,000. On the closing date of the transaction, the lease agreement with NHI is terminated. The Company currently operates and will continue to operate all of the facilities, except four Florida skilled nursing facilities. The four Florida skilled nursing facilities will continue to be subject to a third-party operator’s lease after the closing of the transaction.

We also have two multi-family developments that are currently under construction, both of which we are noncontrolling owners. These developments are located in Franklin, Tennessee and Hermitage, Tennessee with 332 units and 315 units, respectively. Our capital contributions in these developments are included in the line item "Investments in unconsolidated companies" in our interim condensed consolidated balance sheets.

Accrued Risk Reserves

Our accrued professional liability and workers’ compensation reserves totaled $121,129,000 at June 30, 2026 and are a primary area of management focus. We have set aside restricted cash and cash equivalents and marketable securities to fund our estimated professional liability and workers’ compensation liabilities.

As to exposure for professional liability claims, we have developed performance certification criteria to measure and bring focus to the patient care issues most likely to produce professional liability exposure, including in–house acquired pressure ulcers, significant weight loss and numbers of falls. These programs for certification, which we regularly modify and improve, have produced measurable improvements in reducing these incidents. Our experience is that achieving goals in these patient care areas improves both patient and employee satisfaction.

31

Table of Contents

Government Reimbursement Programs

Medicare – Skilled Nursing Facilities

In July 2025, CMS released its final rule outlining fiscal year 2026 Medicare payment rates and policy changes for skilled nursing facilities, which began on October 1, 2025. The fiscal year 2026 rule equates to a net 3.2% increase in Medicare Part A payments to SNFs in fiscal year 2026 compared to 2025 levels. The rule includes a market basket increase of 3.3%, an increase of 0.6% to the market basket forecast error adjustment, and a negative 0.7% productivity adjustment. These figures do not incorporate the SNF Value Based Purchasing (“VBP”) reduction for certain SNFs subject to the net reduction in payments under the SNF VBP; those adjustments are estimated to total $208.4 million in fiscal year 2026.

In July 2026, CMS released its final rule outlining fiscal year 2027 Medicare payment rates and policy changes for skilled nursing facilities, which will begin on October 1, 2026. The fiscal year 2027 proposal equates to a net 2.4% increase in Medicare Part A payments to SNFs in fiscal year 2027 compared to 2026 levels. The rule includes a market basket increase of 3.3% minus a 0.9% productivity adjustment. CMS also finalized its proposals related to the SNF Quality Reporting Program, including the removal of two measures related to COVID-19 vaccination, a shortened data reporting timeline, and the requirement to submit assessment data for all patients regardless of payer.

For the first six months of 2026, our average Medicare per diem rate for skilled nursing facilities incr

[Excerpt truncated for page length; source filing is linked above.]

Latest 10-K MD&A (excerpt)

Latest 10-K Item 7 source: 0001437749-26-005910. The complete FY 2025 MD&A is published at /company/NHC/mda/fy2025/.

Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary. Confidence: high. Filing date: 2026-02-26. Report date: 2025-12-31.

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Overview

National HealthCare Corporation, which we also refer to as NHC or the Company, is a leading provider of post–acute care and senior health care services. At December 31, 2025, we operate or manage 80 skilled nursing facilities with 10,329 1icensed beds, 26 assisted living facilities with 1,413 units, nine independent living facilities, three behavioral health hospitals, 34 homecare agencies, and 33 hospice agencies located in 9 states. In addition, we provide management services, accounting and financial services, and insurance services to third party operators of healthcare properties. We also own the real estate of 10 healthcare properties and lease these properties to third party operators.

30

Executive Summary

Earnings

To monitor our earnings, we have developed budgets and management reports to monitor labor, census, and the composition of revenues. During certain inflationary times, our net patient revenues and government reimbursement may not keep pace with inflationary increases in our expenses, which may cause net earnings to decline.

Occupancy

A primary area of management focus continues to be the rates of occupancy within our skilled nursing facilities. The overall census (based on operational beds) in owned and leased skilled nursing facilities for 2025 was 89.7% compared to 88.6% in 2024 and 87.9% in 2023.

Due to America’s healthcare labor shortage, the challenge of maintaining desirable patient census levels has been amplified. Management has undertaken a number of steps in order to best position our current and future health care facilities. This includes working internally to examine and improve systems to be most responsive to referral sources and payors, as well as find creative initiatives to retain and attract qualified healthcare professionals. Additionally, NHC is in various stages of partnerships with hospital systems, payors, and other post–acute alliances to better position ourselves so we are an active participant in the delivery of post-acute healthcare services.

Quality of Patient Care

The Centers for Medicare and Medicaid Services (“CMS”) introduced the Five-Star Quality Rating System to help consumers, their families and caregivers compare skilled nursing facilities more easily. The Five-Star Quality Rating System gives each skilled nursing operation a rating ranging between one and five stars in various categories (five stars being the best). The Company has always strived for patient-centered care and quality outcomes as precursors to outstanding financial performance.

The tables below summarize NHC's overall performance in these Five-Star ratings versus the skilled nursing industry as of December 31, 2025:

NHC RatingsIndustry Ratings
Total number of skilled nursing facilities, end of period80
Number of 4 and 5-star rated skilled nursing facilities50
Percentage of 4 and 5-star rated skilled nursing facilities62.5%38.6%
Average rating for all skilled nursing facilities, end of period3.832.95

Development and Growth

We are undertaking to expand our post–acute and senior health care operations while protecting our existing operations and markets. The following table lists our recent construction and purchase activities.

Type of OperationDescriptionSizeLocationPlaced in Service
HospiceNew Agency1 agencyCedar Bluff, VAMarch 2023
Skilled NursingAcquisition66 bedsNashville, TNMay 2023
HomecareNew Agency1 agencyTallahassee, FLMay 2023
Assisted Living FacilityNew Operations135 unitsVero Beach, FLJuly 2023
Assisted Living FacilityNew Operations95 unitsMerritt Island, FLJuly 2023
Assisted Living FacilityNew Operations100 unitsStuart, FLJuly 2023
HospiceNew Agency1 agencyMorristown, TNApril 2024
HospiceNew Agency1 agencyLawrenceburg, TNJuly 2024
HospiceNew Agency1 agencyWytheville, VAAugust 2024
HospiceNew Agency1 agencyClinton, TNOctober 2024

On August 1, 2024, the Company purchased the assets of White Oak Management, Inc. (“White Oak”). The White Oak portfolio consisted of 15 skilled nursing facilities, two assisted living facilities, four independent living facilities and a long-term care pharmacy. The White Oak operations have 1,928 licensed skilled nursing beds, 48 assisted living units, and 302 independent living units in the states of South Carolina and North Carolina.

Accrued Risk Reserves

Our accrued professional liability and workers’ compensation reserves totaled $121,595,000 and $103,616,000 at December 31, 2025 and 2024, respectively, and are a primary area of management focus. We have set aside restricted cash and restricted marketable securities to fund our professional liability and workers’ compensation reserves.

As to exposure for professional liability claims, we have developed performance measures to bring focus to the patient care issues most likely to produce professional liability exposure, including in–house acquired pressure ulcers, significant weight loss and numbers of falls. These programs for certification, which we regularly modify and improve, have produced measurable improvements in reducing these incidents. Our experience is that achieving goals in these patient care areas improves both patient and employee satisfaction.

Segment Reporting

The Company has two reportable operating segments: (1) inpatient services, which includes the operation of skilled nursing facilities, assisted and independent living facilities, and behavioral health hospitals; and (2) homecare and hospice services. These reportable operating segments are consistent with information used by the Company’s Chief Executive Officer, as chief operating decision maker (“CODM”), to assess performance and allocate resources. The Company also reports an “all other” category that includes revenues from rental income, management and accounting services fees, insurance services, and costs of the corporate office.

The Company’s CODM evaluates performance including pretax earnings and allocates capital resources to each segment based on an operating model that is designed to improve the quality of patient care and profitability of the Company, while enhancing long-term shareholder value. The CODM does not review assets by segment in his resource allocation and therefore, assets by segment are not disclosed below.

31

The following tables set forth the Company’s consolidated statements of operations by business segment (in thousands):

Year Ended December 31, 2025
Inpatient ServicesHomecare and HospiceAll OtherTotal
Revenues:
Net patient revenues$1,315,545$154,086$$1,469,631
Other revenues1,46746,68348,150
Net operating revenues1,317,012154,08646,6831,517,781
Costs and Expenses:
Salaries, wages and benefits775,47793,53552,068921,080
Other operating336,74627,53712,919377,202
Facility rent35,9722,3737,88246,227
Depreciation and amortization41,0665813,27344,920
Total costs and expenses1,189,261124,02676,1421,389,429
Income (loss) from operations127,75130,060(29,459)128,352
Non-operating income18,10718,107
Interest expense(6,371)(6,371)
Unrealized gains on marketable equity securities22,34422,344
Income before income taxes$121,380$30,060$10,992$162,432
Year Ended December 31, 2024
Inpatient ServicesHomecare and HospiceAll OtherTotal
Revenues:
Net patient revenues$1,111,300$140,459$$1,251,759
Other revenues1,31544,86346,178
Government stimulus income9,4459,445
Net operating revenues and stimulus income1,112,615140,45954,3081,307,382
Costs and Expenses:
Salaries, wages and benefits668,02985,71257,189810,930
Other operating280,86725,92714,596321,390
Facility rent33,7872,2957,10043,182
Depreciation and amortization37,9887373,26041,985
Total costs and expenses1,020,671114,67182,1451,217,487
Income (loss) from operations91,94425,788(27,837)89,895
Non-operating income19,69019,690
Interest expense(4,135)(4,135)
Unrealized gains on marketable equity securities30,95830,958
Income before income taxes$87,809$25,788$22,811$136,408

32

Year Ended December 31, 2023
Inpatient ServicesHomecare and HospiceAll OtherTotal
Revenues:
Net patient revenues$956,077$131,537$$1,087,614
Other revenues1,14152,78953,930
Net operating revenues957,218131,53752,7891,141,544
Costs and Expenses:
Salaries, wages and benefits589,27980,61042,455712,344
Other operating254,55923,52910,095288,183
Facility rent32,5422,1726,81141,525
Depreciation and amortization38,1727863,07642,034
Total costs and expenses914,552107,09762,4371,084,086
Income (loss) from operations42,66624,440(9,648)57,458
Non-operating income16,66016,660
Interest expense(324)(324)
Unrealized gains on marketable equity securities14,94414,944
Income before income taxes$42,342$24,440$21,956$88,738

Results of Operations

The following table and discussion set forth items from the consolidated statements of operations as a percentage of net operating revenues and grant income for the years ended December 31, 2025, 2024 and 2023.

Percentage of Net Operating Revenues

[Excerpt truncated for page length; the complete text is on the linked full-MD&A page.]

Read the full FY 2025 MD&A or browse all MD&A years.

MD&A history

Prior-year 10-K MD&A spans are extracted from SEC filings with the same bounded parser used for the latest filing. Each year's full verbatim text is on its own sub-page.

Macro cross-references for NHC

Indicators mapped to this company's SIC classification (industry 8051 Services-Skilled Nursing Care Facilities) by grepcent's deterministic macro-sector crosswalk. A navigational mapping, not a statistical or causal claim.

Macro-to-micro threads including this sector: US labor market, Growth & output, Government finances, Sector employment.

All 71 macro indicators →

For LLMs & downloads

Markdown twin: /company/NHC.md · JSON record: /company/NHC.json · verified financials: JSON / CSV · machine TOC for the whole site: /llms.txt